Correlation Between Genmab AS and Tff Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Genmab AS and Tff Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genmab AS and Tff Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Genmab AS and Tff Pharmaceuticals, you can compare the effects of market volatilities on Genmab AS and Tff Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genmab AS with a short position of Tff Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genmab AS and Tff Pharmaceuticals.

Diversification Opportunities for Genmab AS and Tff Pharmaceuticals

0.6
  Correlation Coefficient

Poor diversification

The 3 months correlation between Genmab and Tff is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding Genmab AS and Tff Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tff Pharmaceuticals and Genmab AS is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genmab AS are associated (or correlated) with Tff Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tff Pharmaceuticals has no effect on the direction of Genmab AS i.e., Genmab AS and Tff Pharmaceuticals go up and down completely randomly.

Pair Corralation between Genmab AS and Tff Pharmaceuticals

Given the investment horizon of 90 days Genmab AS is expected to generate 0.16 times more return on investment than Tff Pharmaceuticals. However, Genmab AS is 6.43 times less risky than Tff Pharmaceuticals. It trades about -0.14 of its potential returns per unit of risk. Tff Pharmaceuticals is currently generating about -0.06 per unit of risk. If you would invest  2,883  in Genmab AS on September 1, 2024 and sell it today you would lose (733.00) from holding Genmab AS or give up 25.42% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Genmab AS  vs.  Tff Pharmaceuticals

 Performance 
       Timeline  
Genmab AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Genmab AS has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Tff Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Tff Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's technical and fundamental indicators remain relatively invariable which may send shares a bit higher in December 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Genmab AS and Tff Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Genmab AS and Tff Pharmaceuticals

The main advantage of trading using opposite Genmab AS and Tff Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genmab AS position performs unexpectedly, Tff Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tff Pharmaceuticals will offset losses from the drop in Tff Pharmaceuticals' long position.
The idea behind Genmab AS and Tff Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Complementary Tools

Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets